Oxelumab

From WikiProjectMed
Jump to navigation Jump to search
Oxelumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetOX-40 ligand
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6424H9920N1704O2014S42
Molar mass144594.46 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]

Oxelumab was developed by Genentech and co-developed by Roche.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab" (PDF). American Medical Association.